OptimizeRx 

$6.46
0
+$0+0% 今天

統計

當日最高
6.46
當日最低
6.11
52週高點
-
52週低點
-
成交量
1,923
平均成交量
-
市值
120.42M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

30Apr預期
Q3 2025
Q4 2025
下一步
0.01
0.17
0.34
0.51
預期EPS
0.00595
實際EPS
不適用

財務

-21.83%利潤率
未盈利
2019
2020
2021
2022
2023
2024
184.25M營收
-40.22M淨利

分析師評級

$17.57平均目標價
最高預估為 24.00。
來自過去6個月內的 7 則評分。這不是投資建議。
買入
57%
持有
43%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 OPRX.BOATS 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
Show more...
執行長
Mr. Stephen L. Silvestro
員工
128
國家
US
ISIN
US68401U2042

上市

0 Comments

分享你的想法

FAQ

OptimizeRx 今天的股價是多少?
OPRX.BOATS 目前價格為 $6.46 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 OptimizeRx 股價表現。
OptimizeRx 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,OptimizeRx 的股票以代號 OPRX.BOATS 進行交易。
OptimizeRx 的市值是多少?
今天 OptimizeRx 的市值為 120.42M
OptimizeRx 下一次財報日期是什麼時候?
OptimizeRx 將於 April 30, 2026 公布下一次財報。
OptimizeRx 上一季度的財報如何?
OPRX.BOATS 上一季度的財報為每股 0.51 USD,預估為 0.22 USD,帶來 +127.32% 的驚喜。下一季度的預估財報為每股 不適用 USD。
OptimizeRx 去年的營收是多少?
OptimizeRx 去年的營收為 184.25MUSD。
OptimizeRx 去年的淨利是多少?
OPRX.BOATS 去年的淨收益為 -40.22MUSD。
OptimizeRx 有多少名員工?
截至 April 01, 2026,公司共有 128 名員工。
OptimizeRx 位於哪個產業?
OptimizeRx從事於Health Care產業。
OptimizeRx 何時完成拆股?
OptimizeRx 最近沒有進行任何拆股。
OptimizeRx 的總部在哪裡?
OptimizeRx 的總部位於 US 的 Waltham。